Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (192)	8/25/2003 11:40:09 PM
From: tuck	Read Replies (4) of 684

How many have played well? Not many. KDUS is one of the best. So far, a few others are modestly ahead. DOVP is the biggest winner. CTIC has done OK. PRCS is slightly ahead. Many are priced above cash, not because the stock price went up, but because they've burned a year's worth. I'm not sure of any that are at a significant discount anymore, but a few are close (of course, backing out debt and other such things would really whittle the list). INCY, GLGC, CRGN, AGNT (might be up a bit since first presented), perhaps GLFD & ARNA. Of these, I am starting to revisit the first three. Expecting a generally weak market for the next nine months, so not in a rush. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next